Exploring nirmatrelvir derivatives through P2 substituent modifications and warhead innovations targeting the main protease of SARS-CoV-2

The COVID-19 pandemic underscored the urgent need for effective antiviral agents, particularly against coronaviruses, which pose a continuing threat of future outbreaks. Targeting the main protease (Mpro), a key enzyme in viral replication, represents a promising therapeutic strategy. This study inv...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Martins, Felipe Cardoso Prado (VerfasserIn) , Lang, Johannes (VerfasserIn) , Rocho, Fernanda dos Reis (VerfasserIn) , Wang, Xianxian (VerfasserIn) , Bonatto, Vinícius (VerfasserIn) , Lameira, Jerônimo (VerfasserIn) , Klein, Christian D. (VerfasserIn) , Montanari, Carlos Alberto (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: November 2025
In: Archiv der Pharmazie
Year: 2025, Jahrgang: 358, Heft: 11, Pages: 1-21
ISSN:1521-4184
DOI:10.1002/ardp.70158
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1002/ardp.70158
Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/ardp.70158
Volltext
Verfasserangaben:Felipe Cardoso Prado Martins, Johannes Lang, Fernanda dos Reis Rocho, Xianxian Wang, Vinícius Bonatto, Jerônimo Lameira, Christian Klein, Carlos Alberto Montanari

MARC

LEADER 00000naa a2200000 c 4500
001 1962407403
003 DE-627
005 20260224122340.0
007 cr uuu---uuuuu
008 260224s2025 xx |||||o 00| ||eng c
024 7 |a 10.1002/ardp.70158  |2 doi 
035 |a (DE-627)1962407403 
035 |a (DE-599)KXP1962407403 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 32  |2 sdnb 
100 1 |a Martins, Felipe Cardoso Prado  |e VerfasserIn  |4 aut 
245 1 0 |a Exploring nirmatrelvir derivatives through P2 substituent modifications and warhead innovations targeting the main protease of SARS-CoV-2  |c Felipe Cardoso Prado Martins, Johannes Lang, Fernanda dos Reis Rocho, Xianxian Wang, Vinícius Bonatto, Jerônimo Lameira, Christian Klein, Carlos Alberto Montanari 
246 3 0 |a two 
264 1 |c November 2025 
300 |b Illustrationen 
300 |a 21 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online veröffentlicht: 29. November 2025 
500 |a Gesehen am 24.02.2026 
520 |a The COVID-19 pandemic underscored the urgent need for effective antiviral agents, particularly against coronaviruses, which pose a continuing threat of future outbreaks. Targeting the main protease (Mpro), a key enzyme in viral replication, represents a promising therapeutic strategy. This study investigates structural modifications to known Mpro inhibitors, focusing on substitutions at the P2 position to explore alterations in both inhibitory potency and metabolic stability. Computational modeling and biochemical assays revealed that incorporating large, hydrophobic, and π-rich groups, such as the 4-phenylproline, significantly enhances binding affinity. Additionally, we evaluated warheads that have not yet been explored in the context of SARS-CoV-2 Mpro inhibition. Among these, fluoro-vinylsulfone and nitrile groups demonstrated superior inhibitory activity. A fragment-merging strategy combining an optimized P2 substituent with the nitrile warhead yielded a hybrid molecule with binding affinity comparable to nirmatrelvir. However, other analogs incorporating individual warhead optimizations displayed similar potency. These findings generate valuable insights into the design of robust Mpro inhibitors and support their potential development as broad-spectrum antiviral agents. 
650 4 |a cysteine protease 
650 4 |a Mpro inhibition 
650 4 |a SARS-CoV-2 
650 4 |a structure-activity relationships 
700 1 |a Lang, Johannes  |d 1996-  |e VerfasserIn  |0 (DE-588)127226422X  |0 (DE-627)1821166086  |4 aut 
700 1 |a Rocho, Fernanda dos Reis  |e VerfasserIn  |4 aut 
700 1 |a Wang, Xianxian  |e VerfasserIn  |0 (DE-588)1240862253  |0 (DE-627)1769945202  |4 aut 
700 1 |a Bonatto, Vinícius  |e VerfasserIn  |4 aut 
700 1 |a Lameira, Jerônimo  |e VerfasserIn  |4 aut 
700 1 |a Klein, Christian D.  |e VerfasserIn  |0 (DE-588)1060644894  |0 (DE-627)800410157  |0 (DE-576)416768717  |4 aut 
700 1 |a Montanari, Carlos Alberto  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Archiv der Pharmazie  |d Weinheim : Wiley-VCH, 1972  |g 358(2025), 11 vom: Nov., Artikel-ID e70158, Seite 1-21  |h Online-Ressource  |w (DE-627)30635358X  |w (DE-600)1496815-0  |w (DE-576)090855604  |x 1521-4184  |7 nnas  |a Exploring nirmatrelvir derivatives through P2 substituent modifications and warhead innovations targeting the main protease of SARS-CoV-2 
773 1 8 |g volume:358  |g year:2025  |g number:11  |g month:11  |g elocationid:e70158  |g pages:1-21  |g extent:21  |a Exploring nirmatrelvir derivatives through P2 substituent modifications and warhead innovations targeting the main protease of SARS-CoV-2 
856 4 0 |u https://doi.org/10.1002/ardp.70158  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext  |7 0 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1002/ardp.70158  |x Verlag  |z kostenfrei  |3 Volltext  |7 0 
951 |a AR 
992 |a 20260224 
993 |a Article 
994 |a 2025 
998 |g 1060644894  |a Klein, Christian D.  |m 1060644894:Klein, Christian D.  |d 160000  |d 160100  |e 160000PK1060644894  |e 160100PK1060644894  |k 0/160000/  |k 1/160000/160100/  |p 7 
998 |g 1240862253  |a Wang, Xianxian  |m 1240862253:Wang, Xianxian  |d 910000  |d 950000  |d 950950  |e 910000PW1240862253  |e 950000PW1240862253  |e 950950PW1240862253  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950950/  |p 4 
998 |g 127226422X  |a Lang, Johannes  |m 127226422X:Lang, Johannes  |d 910000  |d 950000  |d 950950  |e 910000PL127226422X  |e 950000PL127226422X  |e 950950PL127226422X  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950950/  |p 2 
999 |a KXP-PPN1962407403  |e 4921789789 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"title":[{"title":"Exploring nirmatrelvir derivatives through P2 substituent modifications and warhead innovations targeting the main protease of SARS-CoV-2","title_sort":"Exploring nirmatrelvir derivatives through P2 substituent modifications and warhead innovations targeting the main protease of SARS-CoV-2"}],"note":["Online veröffentlicht: 29. November 2025","Gesehen am 24.02.2026"],"relHost":[{"recId":"30635358X","pubHistory":["305.1972 -"],"title":[{"subtitle":"Arch Pham","title_sort":"Archiv der Pharmazie","title":"Archiv der Pharmazie"}],"note":["Gesehen am 06.03.24","Fortsetzung der Druck-Ausgabe"],"language":["ger"],"disp":"Exploring nirmatrelvir derivatives through P2 substituent modifications and warhead innovations targeting the main protease of SARS-CoV-2Archiv der Pharmazie","part":{"issue":"11","text":"358(2025), 11 vom: Nov., Artikel-ID e70158, Seite 1-21","volume":"358","extent":"21","year":"2025","pages":"1-21"},"titleAlt":[{"title":"an international journal ; pharmaceutical and medicinal chemistry"}],"physDesc":[{"extent":"Online-Ressource"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"id":{"eki":["30635358X"],"zdb":["1496815-0"],"doi":["10.1002/(ISSN)1521-4184"],"issn":["1521-4184"]},"origin":[{"publisherPlace":"Weinheim","dateIssuedKey":"1972","dateIssuedDisp":"1972-","publisher":"Wiley-VCH"}]}],"recId":"1962407403","person":[{"given":"Felipe Cardoso Prado","role":"aut","family":"Martins","display":"Martins, Felipe Cardoso Prado"},{"role":"aut","given":"Johannes","display":"Lang, Johannes","family":"Lang"},{"display":"Rocho, Fernanda dos Reis","family":"Rocho","role":"aut","given":"Fernanda dos Reis"},{"family":"Wang","display":"Wang, Xianxian","given":"Xianxian","role":"aut"},{"role":"aut","given":"Vinícius","display":"Bonatto, Vinícius","family":"Bonatto"},{"given":"Jerônimo","role":"aut","family":"Lameira","display":"Lameira, Jerônimo"},{"given":"Christian D.","role":"aut","family":"Klein","display":"Klein, Christian D."},{"given":"Carlos Alberto","role":"aut","family":"Montanari","display":"Montanari, Carlos Alberto"}],"id":{"doi":["10.1002/ardp.70158"],"eki":["1962407403"]},"name":{"displayForm":["Felipe Cardoso Prado Martins, Johannes Lang, Fernanda dos Reis Rocho, Xianxian Wang, Vinícius Bonatto, Jerônimo Lameira, Christian Klein, Carlos Alberto Montanari"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"noteIll":"Illustrationen","extent":"21 S."}],"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"November 2025"}]} 
SRT |a MARTINSFELEXPLORINGN2025